FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2168548219> ?p ?o ?g. }

• W2168548219 endingPage "249" @default.
• W2168548219 startingPage "241" @default.
• W2168548219 abstract "From July 1, 1989, through March 31, 2001, 2466 patients with stage I seminoma were evaluated in three randomized noninferiority trials: the TE10, TE18, and TE19 trials. We analyzed mature results of these studies. The TE10 trial randomly assigned 478 patients to para-aortic and ipsilateral iliac lymph node (dogleg field) or para-aortic only radiation therapy (total dose = 30 Gy). The TE18 trial randomly assigned 1094 patients to a total dose of 30 or 20 Gy of radiation therapy, predominantly to a para-aortic field. The TE19 trial randomly assigned 1477 patients to radiation therapy or a single injection of carboplatin at a dose of seven times the area under the curve. Time to relapse was determined from Kaplan–Meier curves, and such data were compared by use of Cox regression models. Noninferiority in TE18 and TE19 required the upper limit of the 90% confidence intervals (CIs) (reflecting the one-sided test for noninferiority at a 5% statistical significance level) to exclude a hazard ratio (HR) of greater than 2.0 and a doubling of the 5-year relapse rates observed in the control arm. The TE10 trial was not powered to exclude clinically relevant differences in overall relapse rates but was assessed against the same criteria. Median follow-up times were 6.4–12 years in the three trials. We identified the noninferiority of the following treatments: 20 Gy of radiation therapy in the TE18 trial (HR of relapse = 0.63, 90% CI = 0.38 to 1.04) and carboplatin in the TE19 trial (HR of relapse = 1.25, 90% CI = 0.83 to 1.89). Para-aortic radiation therapy in the TE10 trial was associated with a hazard ratio of relapse of 1.15 (90% CI = 0.54 to 2.44). Relapse occurred after 3 years in only four (0.2%) of all 2466 patients. Computed tomography scans had little impact on the detection of relapse after radiation therapy; seven of the 904 patients allocated radiation therapy in TE19 had a relapse detected by this method. This large and mature dataset from three randomized trials has provided support for the use of either radiation therapy or carboplatin therapy as adjuvant treatment for stage I seminoma." @default.
• W2168548219 created "2016-06-24" @default.
• W2168548219 creator A5019086869 @default.
• W2168548219 creator A5023188445 @default.
• W2168548219 creator A5039622637 @default.
• W2168548219 creator A5040028722 @default.
• W2168548219 creator A5047234703 @default.
• W2168548219 creator A5062805582 @default.
• W2168548219 creator A5065958068 @default.
• W2168548219 creator A5066576612 @default.
• W2168548219 creator A5071786386 @default.
• W2168548219 date "2011-01-06" @default.
• W2168548219 modified "2023-10-14" @default.
• W2168548219 title "Randomized Trials in 2466 Patients With Stage I Seminoma: Patterns of Relapse and Follow-up" @default.
• W2168548219 cites W1978174896 @default.
• W2168548219 cites W1997773801 @default.
• W2168548219 cites W2018607314 @default.
• W2168548219 cites W2105475112 @default.
• W2168548219 cites W2109175854 @default.
• W2168548219 cites W2120873957 @default.
• W2168548219 cites W2122546849 @default.
• W2168548219 cites W2130803751 @default.
• W2168548219 cites W2136265852 @default.
• W2168548219 cites W2140134446 @default.
• W2168548219 cites W2140944538 @default.
• W2168548219 cites W2166066062 @default.
• W2168548219 cites W2170186442 @default.
• W2168548219 cites W2218229785 @default.
• W2168548219 cites W4210282201 @default.
• W2168548219 cites W4249100950 @default.
• W2168548219 cites W4361742796 @default.
• W2168548219 doi "https://doi.org/10.1093/jnci/djq525" @default.
• W2168548219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21212385" @default.
• W2168548219 hasPublicationYear "2011" @default.
• W2168548219 type Work @default.
• W2168548219 sameAs 2168548219 @default.
• W2168548219 citedByCount "115" @default.
• W2168548219 countsByYear W21685482192012 @default.
• W2168548219 countsByYear W21685482192013 @default.
• W2168548219 countsByYear W21685482192014 @default.
• W2168548219 countsByYear W21685482192015 @default.
• W2168548219 countsByYear W21685482192016 @default.
• W2168548219 countsByYear W21685482192017 @default.
• W2168548219 countsByYear W21685482192018 @default.
• W2168548219 countsByYear W21685482192019 @default.
• W2168548219 countsByYear W21685482192020 @default.
• W2168548219 countsByYear W21685482192021 @default.
• W2168548219 countsByYear W21685482192022 @default.
• W2168548219 countsByYear W21685482192023 @default.
• W2168548219 crossrefType "journal-article" @default.
• W2168548219 hasAuthorship W2168548219A5019086869 @default.
• W2168548219 hasAuthorship W2168548219A5023188445 @default.
• W2168548219 hasAuthorship W2168548219A5039622637 @default.
• W2168548219 hasAuthorship W2168548219A5040028722 @default.
• W2168548219 hasAuthorship W2168548219A5047234703 @default.
• W2168548219 hasAuthorship W2168548219A5062805582 @default.
• W2168548219 hasAuthorship W2168548219A5065958068 @default.
• W2168548219 hasAuthorship W2168548219A5066576612 @default.
• W2168548219 hasAuthorship W2168548219A5071786386 @default.
• W2168548219 hasBestOaLocation W21685482191 @default.
• W2168548219 hasConcept C126322002 @default.
• W2168548219 hasConcept C141071460 @default.
• W2168548219 hasConcept C155806632 @default.
• W2168548219 hasConcept C168563851 @default.
• W2168548219 hasConcept C207103383 @default.
• W2168548219 hasConcept C2776694085 @default.
• W2168548219 hasConcept C2778074268 @default.
• W2168548219 hasConcept C2778239845 @default.
• W2168548219 hasConcept C2781451048 @default.
• W2168548219 hasConcept C2989005 @default.
• W2168548219 hasConcept C44249647 @default.
• W2168548219 hasConcept C50382708 @default.
• W2168548219 hasConcept C509974204 @default.
• W2168548219 hasConcept C71924100 @default.
• W2168548219 hasConceptScore W2168548219C126322002 @default.
• W2168548219 hasConceptScore W2168548219C141071460 @default.
• W2168548219 hasConceptScore W2168548219C155806632 @default.
• W2168548219 hasConceptScore W2168548219C168563851 @default.
• W2168548219 hasConceptScore W2168548219C207103383 @default.
• W2168548219 hasConceptScore W2168548219C2776694085 @default.
• W2168548219 hasConceptScore W2168548219C2778074268 @default.
• W2168548219 hasConceptScore W2168548219C2778239845 @default.
• W2168548219 hasConceptScore W2168548219C2781451048 @default.
• W2168548219 hasConceptScore W2168548219C2989005 @default.
• W2168548219 hasConceptScore W2168548219C44249647 @default.
• W2168548219 hasConceptScore W2168548219C50382708 @default.
• W2168548219 hasConceptScore W2168548219C509974204 @default.
• W2168548219 hasConceptScore W2168548219C71924100 @default.
• W2168548219 hasIssue "3" @default.
• W2168548219 hasLocation W21685482191 @default.
• W2168548219 hasLocation W21685482192 @default.
• W2168548219 hasOpenAccess W2168548219 @default.
• W2168548219 hasPrimaryLocation W21685482191 @default.
• W2168548219 hasRelatedWork W1500519547 @default.
• W2168548219 hasRelatedWork W1727188710 @default.
• W2168548219 hasRelatedWork W2037461395 @default.
• W2168548219 hasRelatedWork W2064613886 @default.
• W2168548219 hasRelatedWork W2119154902 @default.

• next